MACARTNEY LAWSON 4
4 · Viking Therapeutics, Inc. · Filed Apr 18, 2023
Insider Transaction Report
Form 4
MACARTNEY LAWSON
Director
Transactions
- Sale
Common Stock, par value $0.00001 per share
2023-04-17$20.00/sh−20,786$415,720→ 47,965 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-04-17−20,786→ 0 totalExercise: $8.00From: 2016-05-26Exp: 2025-04-28→ Common Stock (20,786 underlying) - Exercise/Conversion
Common Stock, par value $0.00001 per share
2023-04-17$8.00/sh+20,786$166,288→ 68,751 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person.
- [F2]100% of the shares subject to the option vested on May 26, 2016, the date of the Issuer's first Annual Meeting of Stockholders following the date of grant.